Showing results (1141-1150 of 2,556) with videos related to
Sort By:
Pageof 256
Therapeutics and Clinical Risk Management|March 19, 2019
Treatment with Saccharomyces boulardii and Escherichia coli Nissle is safe and associated with reduced nosocomial transmission of vanB vancomycin-resistant Enterococcus faecium on an early rehabilitation ward in Germany: a retrospective analysisStefan Borgmann, Beate Rieß, Rabea Siegmund, et al.Therapeutics and Clinical Risk Management|March 19, 2019
Adherence to recommended clinical guidelines in extensive disease small-cell lung cancer across the US, Europe, and JapanMarco D DiBonaventura, Bijal Shah-Manek, Karen Higginbottom, et al.Therapeutics and Clinical Risk Management|April 11, 2017
Comparison of prophylactic effect of UGIB and effects on platelet function between PPIs and H2RAs combined with DAPT: systematic review and meta-analysisZhan-Miao Yi, Ting-Ting Qiu, Yuan Zhang, et al.Therapeutics and Clinical Risk Management|April 11, 2017
Urinary cadmium levels predict mortality of patients with acute heart failureChing-Wei Hsu, Cheng-Hao Weng, Cheng-Chia Lee, et al.Therapeutics and Clinical Risk Management|April 25, 2017
Role of pirfenidone in the management of pulmonary fibrosisKeith C Meyer, Catherine A DeckerTherapeutics and Clinical Risk Management|June 3, 2008
Management of patients with newly diagnosed malignant primary brain tumors with a focus on the evolving role of temozolomideMark R Gilbert, Terri S ArmstrongTherapeutics and Clinical Risk Management|June 3, 2008
Impact of Pharmaceutical Care interventions in the identification and resolution of drug-related problems and on quality of life in a group of elderly outpatients in Ribeirão Preto (SP), BrazilDivaldo Pereira de Lyra, Nadir Kheir, Juliana Palma Abriata, et al.Therapeutics and Clinical Risk Management|June 3, 2008
The role of entecavir in the treatment of chronic hepatitis BEvangelini Dimou, Vasilios Papadimitropoulos, Stephanos J HadziyannisTherapeutics and Clinical Risk Management|June 3, 2008
Shared decision-making based on different features of risk in the context of diabetes mellitus and rheumatoid arthritisMonica OrtendahlTherapeutics and Clinical Risk Management|March 7, 2017
Psychological factors as risk factors for poor hip function after total hip arthroplastyAchim Benditz, Petra Jansen, Jan Schaible, et al.Pageof 256